申请人:Takahashi Keiji
公开号:US20090118304A1
公开(公告)日:2009-05-07
Disclosed is a compound represented by the formula (I) below, which has a glucokinase-activating effect and is thus useful for treatment of diabetes or obesity, or a pharmaceutically acceptable salt thereof.
In the formula, R
1
represents an aryl or the like; R
11
represents an aryl or the like; R
2
represents a formyl or the like, R
3
represents a C
1-6
alkyl or the like; R
3
represents a hydrogen atom or the like; Z
1
represents —O— or the like; Z
2
represents —O— or the like; Y
1
-Y
4
respectively represent a carbon atom or a nitrogen atom; ring A represents a heteroaryl group; X represents a carbon atom or the like; m represents an integer of 0-2; and q represents an integer of 0-2.
本发明涉及一种化合物,其公式如下(I),具有激活葡萄糖激酶的作用,因此可用于治疗糖尿病或肥胖症,或其药学上可接受的盐。在公式中,R1代表芳基或类似物; R11代表芳基或类似物; R2代表甲酰基或类似物,R3代表C1-6烷基或类似物; R3代表氢原子或类似物; Z1代表—O—或类似物; Z2代表—O—或类似物; Y1-Y4分别代表碳原子或氮原子; 环A代表杂环芳基; X代表碳原子或类似物; m代表0-2的整数; q代表0-2的整数。